Copyright: ©Author(s) 2026.
World J Gastroenterol. May 7, 2026; 32(17): 116867
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.116867
Published online May 7, 2026. doi: 10.3748/wjg.v32.i17.116867
Table 2 Summary of outcomes in patients with and without post-transjugular intrahepatic portosystemic shunt rebleeding before and after propensity score matching
| Characteristics | Before PSM | After PSM | ||||||||
| Total | No post-TIPS rebleeding | Post-TIPS rebleeding | P value | SMD | Total | No post-TIPS rebleeding | Post-TIPS rebleeding | P value | SMD | |
| Overt hepatic encephalopathy | 599 (33.6) | 466 (32.5) | 133 (38.4) | 0.040 | 0.125 | 349 (34.0) | 218 (32.0) | 131 (38.1) | 0.060 | 0.128 |
| All-cause death | 530 (29.7) | 390 (27.2) | 140 (40.5) | < 0.001 | 0.284 | 324 (31.6) | 184 (27.0) | 140 (40.7) | < 0.001 | 0.293 |
| Liver-related death | 429 (24.1) | 306 (21.3) | 123 (35.5) | < 0.001 | 0.320 | 270 (26.3) | 147 (21.6) | 123 (35.8) | < 0.001 | 0.318 |
- Citation: Zhu JY, Tie J, Xia YF, Wang GC, Zhuge YZ, Wu H, Zhu XL, Xue H, Xu J, Zhang F, Zhao LH, Huang GJ, Zhang MY, Li Z, Wei B, Li PJ, Wang Z, Wu W, Chen C, Tang CW, Zhang CQ. Impact of rebleeding after transjugular intrahepatic portosystemic shunt on liver-related death based on liver function categories. World J Gastroenterol 2026; 32(17): 116867
- URL: https://www.wjgnet.com/1007-9327/full/v32/i17/116867.htm
- DOI: https://dx.doi.org/10.3748/wjg.v32.i17.116867